Selective IgA Deficiency
The most likely diagnosis is selective IgA deficiency, which is the most common primary immunodeficiency and classically presents with anaphylactic transfusion reactions in patients with atopic histories who receive blood products containing IgA.
Clinical Reasoning
This patient's presentation is pathognomonic for an IgA-mediated anaphylactic transfusion reaction:
- Atopic triad present: Asthma, eczema, and recurrent pneumonias suggest underlying immunodeficiency
- Anaphylaxis during transfusion: Generalized hives plus hypotension (BP dropped from 90/60 to 70/40 mm Hg) meets diagnostic criteria for anaphylaxis 1
- Appropriate blood type given: O Rh-negative packed RBCs were correctly matched, ruling out ABO/Rh incompatibility
- Rapid onset during transfusion: Symptoms developed during the transfusion itself, consistent with immediate hypersensitivity
Why Selective IgA Deficiency?
Patients with selective IgA deficiency (affecting 1:300-700 individuals) can develop anti-IgA antibodies. When they receive blood products containing even trace amounts of IgA from donors, these antibodies trigger severe anaphylactic reactions. Key features supporting this diagnosis:
- Recurrent sinopulmonary infections (multiple pneumonias) are the hallmark clinical manifestation
- Atopic conditions (asthma, eczema) occur with increased frequency
- Anaphylaxis to blood products is the most dramatic and life-threatening complication
- The reaction occurred despite correct ABO/Rh typing
Why Not the Other Options?
Blood group incompatibility: Excluded because she received appropriately typed O Rh-negative blood. ABO incompatibility would cause hemolysis, not isolated anaphylaxis with urticaria.
Bacterial contamination: Would present with high fever, rigors, and septic shock—not isolated urticaria and anaphylaxis. The rapid response to epinephrine also argues against bacterial contamination.
Hyper-IgM syndrome: While this causes recurrent infections, it's X-linked (rare in females) and doesn't typically cause transfusion anaphylaxis. The mechanism wouldn't explain anti-IgA antibody formation.
Management Implications
The appropriate treatment was administered—intramuscular epinephrine is first-line therapy for anaphylaxis 1. Despite theoretical concerns about epinephrine in pregnancy, the evidence is clear that maternal hypotension poses far greater risk to the fetus than epinephrine administration 2, 3, 4.
Future Transfusion Strategy
For this patient going forward:
- Use washed RBCs or IgA-deficient blood products for all future transfusions
- Document IgA deficiency prominently in medical records
- Consider formal immunology workup postpartum to confirm diagnosis and measure IgA levels
- Counsel regarding risks with future blood product exposure
Common Pitfall
The critical error would be attributing this reaction to "routine transfusion reaction" and not recognizing the underlying IgA deficiency. This patient will require special blood products for life, and failure to identify this puts her at risk for repeated life-threatening anaphylaxis with future transfusions or IV immunoglobulin administration.